UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
EU approvals for Samsung Bioepis push up share prices
Investors are showing higher expectation for Samsung Bioepis, a Samsung Gro...
by Nam Doo-hyun
|
2017-09-18 14:45
라인
‘Knowledge’ is core ability for bio industrialists, survey says
“Knowledge” is the most important element for people engaged in bio and hea...
by Nam Doo-hyun
|
2017-09-15 16:28
라인
Experts call for overhauling bio industry promotion policy
Before the announcement of the “third draft to enhance biotechnology,” expe...
by Nam Doo-hyun
|
2017-09-15 15:39
라인
New VC investments in bio, medical fields fall sharpest in H1
New venture capital investments in bio and medical industries have fallen m...
by Nam Doo-hyun
|
2017-09-13 13:23
라인
China, Australia emerge as promising markets for medical equipment makers
Australia has emerged as the promising market for Korean medical equipment ...
by Nam Doo-hyun
|
2017-09-12 17:40
라인
Brokerage analyzes profit-sharing structure of Celltrion group
Local stock analysts’ eyes are now on the profit-sharing structure of the C...
by Nam Doo-hyun
|
2017-09-12 16:55
라인
Drugmakers adopt VR in sales, promotion
Korean drugmakers have set out to use virtual reality programs to promote a...
by Nam Doo-hyun
|
2017-09-11 17:21
라인
Experts stress need for drug treatments to control cholesterol
Korean Society of Lipid & Atherosclerosis (KSoLA) has come out to emphasize...
by Nam Doo-hyun
|
2017-09-11 12:01
라인
Investment into GMP facility needed to export bio medicines
It is urgent for the government to invest in the construction of Good Manuf...
by Nam Doo-hyun
|
2017-09-11 11:59
라인
Drugmakers introduce VR for diabetes therapy
Chong Kun Dang Pharmaceutical종근당(CEO: Kim Young-joo 김영주) and MSD Korea 한국MS...
by Nam Doo-hyun
|
2017-09-06 17:12
라인
Papers related to stem cell therapy rising worldwide
Seoul National University서울대학교, Catholic University of Korea가톨릭대학교, and Sch...
by Nam Doo-hyun
|
2017-09-06 16:45
라인
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks
Amid escalating North Korea risks caused by the North’s nuclear and missile...
by Nam Doo-hyun
|
2017-09-05 16:45
라인
Survey tracks reasons Chinese come to Korea for cosmetic surgery
What makes Chinese tourists come to Korea for cosmetic surgery to account f...
by Nam Doo-hyun
|
2017-09-04 14:20
라인
‘AI to boost success rates, effectiveness for clinical trials’
Artificial intelligence such as rote learning is expected to boost success ...
by Nam Doo-hyun
|
2017-08-28 14:34
라인
Ferring’s offshoot swindled by email mimicking headquarter office
Ferring Pharmaceuticals has recently been conned out of tens of millions of...
by Nam Doo-hyun
|
2017-08-25 17:54
라인
Pharmaceutical sectors of major countries show mixed results
Korea, U.S., and Japanese pharmaceutical industries recorded trade deficits...
by Nam Doo-hyun
|
2017-08-24 18:35
라인
Quadrivalent influenza vaccines enter fierce sales competition
The competition among quadrivalent products is increasingly intensifying in...
by Nam Doo-hyun
|
2017-08-24 15:04
라인
Bio firms blame small R&D spending for low technology
Korea’s bio businesses cite “lack of R&D investment” as the main reason for...
by Nam Doo-hyun
|
2017-08-24 11:31
라인
Triumeq aims to change HIV drug market with easy use
GSK has released Triumeq Tab. to treat human immunodeficiency virus(HIV), d...
by Nam Doo-hyun
|
2017-08-23 12:12
라인
Celltrion’s move to main stock market draws investor concern
The recent decision by Celltrion, Korea’s most successful biosimilar maker,...
by Nam Doo-hyun
|
2017-08-22 17:01
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top